Drugs for Graves' Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 182)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Propylthiouracil |
Approved, Investigational |
Phase 4,Phase 3,Phase 2 |
|
51-52-5 |
657298
|
Synonyms:
2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone
2,3-Dihydro-6-propyl-2-thioxo-4(1H)-pyrimidinone
2-Mercapto-4-hydroxy-6-n-propylpyrimidine
2-mercapto-6-Propyl-4-pyrimidone
2-Mercapto-6-propyl-4-pyrimidone
2-mercapto-6-Propylpyrimid-4-one
2-Mercapto-6-propylpyrimid-4-one
2-Mercapto-6-propylpyrimidin-4-ol
2-thio-4-oxo-6-Propyl-1,3-pyrimidine
2-Thio-4-oxo-6-propyl-1,3-pyrimidine
2-thio-6-Propyl-1,3-pyrimidin-4-one
2-Thio-6-propyl-1,3-pyrimidin-4-one
46698_FLUKA
46698_RIEDEL
4-Hydroxy-2-mercapto-6-propylpyrimidine
4-Propyl-2-thiouracil
500-50-5
51-52-5
6 Propyl 2 thiouracil
6 Propyl 2 Thiouracil
6-(n-Propyl)-2-thiouracil
6-n-PROPYL-2-MERCAPTO-4-HYDROXYPYRIMIDINE
6-N-Propyl-2-thiouracil
6-N-Propylthiouracil
6-Prop yl-2-thiouracil
6-Propil-tiouracile
6-Propil-tiouracile [Italian]
6-propyl-2 thiouracil
6-propyl-2-sulfanylidene-1H-pyrimidin-4-one
6-propyl-2-sulfanylidene-2,3-dihydropyrimidin-4(1H)-one
6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione
6-Propyl-2-thio-2,4(1H,3H)-pyrimidinedione
6-propyl-2-thiopyrimidine-2,4(1H,3H)-dione
6-Propyl-2-thiouracil
6-propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one
6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one
6-Propylthiouracil
6-thio-4-Propyluracil
6-Thio-4-propyluracil
AC-10795
AC1LCWBA
AI3-25477
AKOS000120319
AKOS001053246
BPBio1_000427
BRD-K48168960-001-04-4
BRD-K48168960-001-05-1
BSPBio_000387
BSPBio_003402
C07569
C7H10N2OS
CAS-51-52-5
CCRIS 544
CHEBI:8502
CHEMBL1518
CID657298
CPD000058275
CPD-11429
D00562
D011441
DB00550
DivK1c_000268
EINECS 200-103-2
F3097-4245
HC210060
HMS1569D09
HMS1766D22
HMS1920L22
HMS2092E03
HMS500N10
HSDB 3390
I03-0144
IDI1_000268
InChI=1/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11
KBio1_000268
KBio2_001356
KBio2_003924
KBio2_006492
KBio3_002622
KBioGR_001003
KBioSS_001356
|
LS-158
MLS000028494
MLS002303010
MolPort-000-145-889
MolPort-000-664-275
MolPort-004-414-251
NCGC00016229-01
NCGC00016229-02
NCGC00022715-03
NCGC00090881-01
NCGC00090881-02
NCGC00090881-03
NCGC00178089-01
NCGC00178089-02
NCGC00183321-01
NINDS_000268
NSC 6498
NSC6498
NSC70461
P0533
P3755_SIGMA
Prestwick_810
Prestwick0_000494
Prestwick1_000494
Prestwick2_000494
Prestwick3_000494
Procasil
Propacil
Propilthiouracil
Propiltiouracile
Propiltiouracile [DCIT]
Propiltiouracilo
Propiltiouracilo [INN-Spanish]
Propycil
PROPYL THIOURACIL
Propyl-thiorist
Propyl-Thiorist
Propylthiorit
Propyl-thiorit
Propyl-Thiorit
propylthiouracil
Propylthiouracil
Propylthiouracil (JP15/USP/INN)
Propylthiouracil (TN)
Propylthiouracil [INN:BAN:JAN]
Propylthiouracile
Propylthiouracile [INN-French]
Propylthiouracilum
Propylthiouracilum [INN-Latin]
Propyl-thyracil
Propyl-Thyracil
Propythiouracil
Prothiucil
Prothiurone
Prothycil
Prothyran
Protiural
PTU
PTU (thyreostatic)
ptu(thyreostatic)
S1988_Selleck
SAM002554926
SBB003855
SMR000058275
SPBio_001363
SPBio_002308
Spectrum_000876
SPECTRUM1500515
Spectrum2_001302
Spectrum3_001731
Spectrum4_000492
Spectrum5_001815
T0517-6237
Thiuragyl
thyreos tat ii
Thyreostat II
thyreostat propyl-thyracil
UNII-721M9407IY
WLN: T6MYMVJ BUS F3
ZINC04640636
ZINC18213075
|
|
2 |
|
Methylprednisolone |
Approved, Vet_approved |
Phase 4,Phase 2,Phase 3,Not Applicable |
|
83-43-2 |
6741
|
Synonyms:
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
1-dehydro-6alpha-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6a-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6-alpha-Methylprednisolone
6a-Methyl-11b,17a,21-triol-1,4-pregnadiene-3,20-dione
6-Methylprednisolone
6α-methyl-11β,17α,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-wyeth
Artisone-Wyeth
Besonia
Bio-0658
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
delta(1)-6alpha-Methylhydrocortisone
Delta(1)-6alpha-Methylhydrocortisone
delta(1)-6a-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
Lemod
LMST02030178
LS-118498
M0639_SIGMA
M1665
Medesone
Medixon
Medlone 21
Medrate
Medric acid
|
Medrol
Medrol (TN)
Medrol adt pak
Medrol Adt Pak
Medrol dosepak
Medrol Dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
MEPRDL
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
methylprednisolone
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
methylprenisolone
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [Dcit]
Metilprednisolone [DCIT]
Metipred
Metrisone
Metrocort
Metysolon
MLS000028541
MLS001148159
MLS002207191
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
Nirypan
Noretona
NSC19987
NSC-19987
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick_622
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Promacortine
Reactenol
S1733_Selleck
SAM002589984
Sieropresol
SMR000058330
Solomet
SPBio_002377
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
δ(1)-6a-methylhydrocortisone
δ(1)-6α-methylhydrocortisone
|
|
3 |
|
Prednisolone phosphate |
Approved, Vet_approved |
Phase 4,Phase 2,Phase 3,Not Applicable |
|
302-25-0 |
|
Synonyms:
Prednisolone 21-(dihydrogen phosphate)
Prednisolone 21-monophosphate
|
Prednisolone 21-phosphate
|
|
4 |
|
Prednisolone |
Approved, Vet_approved |
Phase 4,Phase 2,Phase 3,Not Applicable |
|
50-24-8 |
5755
|
Synonyms:
(11b)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11b,17a,21-triol-3,20-dione
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11b,17a,21-triol
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1,4-pregnadiene-3,20-dione-11β,17α,21-triol
1,4-Pregnadiene-3,20-dione-11β,17α,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11b,17a,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
Bio-0666
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
Codelcortone
Co-Hydeltra
CO-Hydeltra
component of Ataraxoid
component of K-Predne-Dome
Cordrol
Cortalone
Cotogesic
Cotolone
CPD000718761
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
delta(1)-Cortisol
delta(1)-Dehydrocortisol
Delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
Delta(1)-dehydrohydrocortisone
Delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
Delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Deltacortenol
Deltacortril
Deltacortril Enteric
delta-dehydrocortisol
delta-dehydrohydrocortisone
Delta-Ef-Cortelan
delta-hydrocortisone
Deltahydrocortisone
Deltasolone
Delta-stab
Delta-Stab
Deltisilone
Depo-Medrol
Derpo Pd
Derpo PD
Dexa-Cortidelt hostacortin H
Dexa-Cortidelt Hostacortin H
Di adreson F
Di Adreson F
Di-adreson F
Di-Adreson F
Di-adreson-F
DiAdresonF
Di-Adreson-F
Dicortol
Donisolone
Dydeltrone
Eazolin D
Econopred
Econopred Plus
EINECS 200-021-7
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
Hostacortin H
HSDB 3385
Hydeltra
Hydeltrasol
Hydeltra-Tba
|
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
Inflamase Forte
Inflamase Mild
I-Pred
K 1557
Key-Pred
Klismacort
Lentosone
Lite Pred
LMST02030179
LS-7669
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone acetate
Methylprednisolone Acetate
Meticortelone
Meti-Derm
Metreton
MLS001304083
MLS002154250
MLS002207037
MolPort-002-507-147
M-Predrol
NCGC00179649-01
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
NSC 9120
NSC9120
NSC9900
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
PRDL
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
PRED-G
Predisolone sodium phosphate
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Prednicen
Predni-Dome
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
prednisolone
Prednisolone (anhydrous)
Prednisolone (JP15/USP/INN)
Prednisolone [INN:BAN:JAN]
Prednisolone acetate
Prednisolone Acetate
Prednisolone sodium phosphate
Prednisolone Sodium Phosphate
Prednisolone tebutate
Prednisolone Tebutate
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick_404
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Rolisone
S1737_Selleck
SAM002264639
Scherisolon
SMR000718761
Solone
SPBio_002367
Steran
Sterane
Sterolone
Supercortisol
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-hydrogen
Ultracortene-Hydrogen
UNII-9PHQ9Y1OLM
ZINC03833821
δ(1)-dehydrocortisol
δ(1)-dehydrohydrocortisone
δ(1)-hydrocortisone
|
|
5 |
|
Methylprednisolone hemisuccinate |
Approved |
Phase 4,Phase 2,Phase 3,Not Applicable |
|
2921-57-5 |
|
Synonyms:
Methylprednisolone hydrogen succinate
|
Methylprednisolone succinate
|
|
6 |
|
Prednisone |
Approved, Vet_approved |
Phase 4,Phase 2,Phase 3 |
|
53-03-2 |
5865
|
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17a,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17α,21-diol-3,11,20-trione
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
Acis brand OF prednisone
ACon0_000082
ACon1_000297
Adasone
AI3-52939
Ancortone
apo-Prednisone
Apo-prednisone
Apo-Prednisone
Apotex brand OF prednisone
Aventis brand OF prednisone
Betapar
Bicortone
Bio-0649
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
C07370
C21H26O5
Cartancyl
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
CPD001227202
Cutason
Dacorten
Dacortin
DB00635
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
delta cortelan
Delta Cortelan
Delta E
Delta E.
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
Delta-cortelan
Delta-Cortelan
Deltacortene
delta-Cortisone
Deltacortisone
Delta-cortisone
delta-Cortone
Deltacortone
Delta-cortone
Delta-dome
Delta-Dome
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Diadreson
Di-Adreson
Diba brand OF prednisone
Econosone
EINECS 200-160-3
Encorton
Encortone
Enkortolon
Enkorton
Fawns and mcallan brand OF prednisone
Fernisone
Ferring brand OF prednisone
Fiasone
GALENpharma brand OF prednisone
Halsey drug brand OF prednisone
Hexal brand OF prednisone
HMS1568O15
HMS2090J13
|
Hoechst brand OF prednisone
Hostacortin
HSDB 3168
ICN brand OF prednisone
Incocortyl
In-Sone
Juvason
Kortancyl
Lichtenstein brand OF prednisone
Liquid pred
Liquid Pred
Lisacort
LMST02030180
Lodotra
LS-1325
MEGxm0_000443
Me-Korti
Merck brand OF prednisone
Merz brand OF prednisone
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
Mibe brand OF prednisone
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI60_000008
NCI-C04897
Nisona
Nizon
Novoprednisone
NSC 10023
NSC10023
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Pharmacia brand OF prednisone
PRD
Precort
Predeltin
Predni tablinen
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Predniment
Prednison
Prednison acsis
Prednison galen
Prednison hexal
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone [INN:BAN]
Prednisone Intensol
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick_405
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
Schering-plough brand OF prednisone
Seatrace brand OF prednisone
Servisone
SK-Prednisone
SMR000718760
SMR001227202
Solvay brand OF prednisone
Sone
SPBio_002214
Sterapred
Supercortil
Trommsdorff brand OF prednisone
U 6020
Ultracorten
Ultracortene
UNII-VB0R961HZT
Winpred
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Wojtab
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
ZINC03875357
|
|
7 |
|
Hyaluronic acid |
Approved, Vet_approved |
Phase 4,Not Applicable |
|
9004-61-9 |
53477741
|
Synonyms:
|
8 |
|
Iodine |
Approved, Investigational |
Phase 4,Phase 2,Phase 3,Not Applicable |
|
7553-56-2 |
807
|
Synonyms:
diiodine
I2
Iode
Iodine-molecule
Iodio
Iodum
|
Jod
Jood
molecular iodine
Molecular iodine
Tincture iodine
|
|
9 |
|
Triamcinolone |
Approved, Vet_approved |
Phase 4,Not Applicable |
|
124-94-7 |
31307
|
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11b,16a,17a,21-Tetrahydroxy-9a-fluoro-1,4-pregnadiene-3,20-dione
11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoro-1,4-pregnadiene-3,20-dione
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9a-fluoro-11b,16a,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9a-fluoro-11b,16a,17a,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9a-fluoro-16a-Hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-fluoro-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-fluoro-11beta,16alpha,17alpha,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-fluoro-16alpha-Hydroxyprednisolone
9alpha-Fluoro-16alpha-hydroxyprednisolone
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-fluoro-11b,16a,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9-fluoro-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-16α-hydroxyprednisolone
AC1L1LDH
AC1Q5HJC
AC-2072
Adcortyl
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
Bio-0662
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
C21H27FO6
Celeste
CHEMBL1451
CID31307
Cinolone
Cinolone-T
CL 19823
D00385
D014221
DB00620
Delphicort
droxypregna-1,4-diene-3,20-dione
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
ione
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-Ag
Kenacort-AG
Kenalog
Kenalog in Orabase
|
Kenalog-10
Kenalog-40
Kenalog-H
Ledercort
Lopac0_001179
LS-698
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
Nasacort
Nasacort Aq
Nasacort Hfa
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
nchembio.2007.53-comp7
NCI60_000750
NSC 13397
NSC13397
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick_438
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Rodinolone
S1933_Selleck
Sk-Triamcinolone
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
T6376_SIGMA
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Triacet
Triacort
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
triamcinolone
Triamcinolone (JP15/USP/INN)
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triam-Tablinen
Triatex
Tricortale
Triderm
Trilone
Tri-Nasal
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
|
|
10 |
|
Acetylcholine |
Approved |
Phase 4,Phase 2,Phase 3 |
|
51-84-3 |
187
|
Synonyms:
2-(Acetyloxy)-N,N,N-trimethylethanaminium
Acetilcolina cusi
Acetyl choline ion
Acetylcholine bromide
Acetylcholine cation
acetylcholine chloride
Acetylcholine chloride
Acetylcholine Chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
Acetylcholinium: acetyl-choline
ACh
|
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
11 |
|
Dexamethasone |
Approved, Investigational, Vet_approved |
Phase 4,Phase 1 |
|
50-02-2 |
5743
|
Synonyms:
(3H)-Dexamethasone
.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol
.gamma.corten
137098-19-2
16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol
16.alpha.-Methyl-9.alpha.-fluoroprednisolone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16a-Methyl-9a-fluoro-1-dehydrocortisol
16α-methyl-9α-fluoro-1-dehydrocortisol
16α-Methyl-9α-fluoro-1-dehydrocortisol
1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone
1-dehydro-16alpha -Methyl-9alpha -fluorohydrocortisone
1-dehydro-16alpha-Methyl-9alpha-fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-dehydro-16a-Methyl-9a-fluorohydrocortisone
1-dehydro-16α-methyl-9α-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
23495-06-9
31375_FLUKA
46165_FLUKA
46165_RIEDEL
50-02-2
8054-59-9
9.alpha.-Fluoro-16.alpha.-methylprednisolone
906422-84-2
9a-fluoro-16a-Methylprednisolone
9a-fluoro-16BETA-METHYLPREDNISOLONE
9A-FLUORO-16BETA-METHYLPREDNISOLONE
9alpha -fluoro-16alpha -Methylprednisolone
9alpha-fluoro-16alpha-Methylprednisolone
9alpha-fluoro-16alpha-Methyl-prednisolone
9-alpha-fluoro-16-alpha-Methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9-fluoro-11,17,21-Trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-fluoro-11alpha -Methylpregna-1,4-diene-3,20-dione
9-fluoro-16-Methylprednisolone
9α-fluoro-16α-methylprednisolone
9α-Fluoro-16α-methylprednisolone
AC-11056
AC1L1L1H
AC1Q29DM
Adexone
Aeroseb-D
Aeroseb-dex
Aeroseb-Dex
AI3-50934
Ak dex OPH otic soln 0.1%
Alcon brand OF dexamethasone
Alcon Brand of Dexamethasone
alpha -fluoro-16-alpha -Methylcortisol
Anaflogistico
Aphtasolon
Aphthasolone
apo-Dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (veterinary)
Azium (Veterinary)
BIDD:ER0494
BIDD:PXR0060
Bisu Ds
Bisu DS
BRD-K38775274-001-02-3
BRD-K38775274-001-06-4
BSPBio_000995
C15643
C22H29FO5
Calonat
CCRIS 7067
CHEBI:41879
CHEMBL384467
CID5743
Corson
Corsone
Cortisumman
CPD001227192
CPD-10549
D00292
D003907
D1756_SIGMA
D4902_SIGMA
D6645_SIGMA
D8893_SIGMA
D9184_SIGMA
DB01234
Decacort
Decacortin
Decaderm
Decadron
Decadron (TN)
Decadron Tablets, Elixir
Decadron, Dexamethasone
Decadron-La
Decadron-LA
Decagel
Decaject
Decaject l.a.
Decaject L.A.
Decaject-l.a.
Decaject-L.A.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta1-9alpha-Fluoro-16alpha-methylcortisol
Delta1-9alpha-fluoro-16alpha-Methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [Dcit]
Desametasone [DCIT]
Desamethasone
Desameton
Deseronil
DEX
Dexa
DEXA
Dexa mamallet
Dexa Mamallet
Dexacen-4
Dexacidin
Dexacort
Dexacortal
Dexa-cortidelt
Dexa-Cortidelt
Dexacortin
Dexa-cortisyl
Dexa-Cortisyl
Dexadeltone
Dexafarma
Dexair
Dexalona
Dexaltin
Dexa-Mamallet
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
Dexameth
Dexamethansone
dexamethasone
Dexamethasone
Dexamethasone (JP15/USP/INN)
|
Dexamethasone [INN:BAN:JAN]
Dexamethasone acetate
Dexamethasone Acetate
Dexamethasone alcohol
Dexamethasone Alcohol
Dexamethasone base
Dexamethasone Base
Dexamethasone intensol
Dexamethasone Intensol
Dexamethasone sodium phosphate
Dexamethasone Sodium Phosphate
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexa-scheroson
Dexa-Scheroson
Dexa-sine
Dexa-Sine
Dexason
Dexasone
Dexasone 0.5MG
Dexasone 0.75MG
Dexasone 4MG
Dexasporin
Dex-ide
Dex-Ide
Dexinolon
Dexinoral
Dexone
Dexone 0.5
DEXONE 0.5
Dexone 0.75
DEXONE 0.75
Dexone 1.5
DEXONE 1.5
Dexone 4
DEXONE 4
Dexonium
Dexpak
Dextelan
Dezone
Dinormon
DXM
Dxms
DXMS
ECR brand OF dexamethasone
ECR Brand of Dexamethasone
EINECS 200-003-9
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy brand OF dexamethasone
Foy Brand of Dexamethasone
FT-0080377
Gammacorten
Hexadecadrol
Hexadrol
Hexadrol elixir
Hexadrol Elixir
Hexadrol Tablets
Hl-dex
Hl-Dex
HL-Dex
HMS1792A17
HMS1990A17
HMS2089N13
HSDB 3053
I06-1196
ICN brand OF dexamethasone
ICN Brand of Dexamethasone
IontoDex
isopto-Dex
Isopto-Dex
Lokalison F
Loverine
LS-7300
Luxazone
Maxidex
Maxidex ont 0.1%
Maxidex sus 0.1%
Maxitrol
Mediamethasone
Merck brand OF dexamethasone
Merck Brand of Dexamethasone
Merz brand 1 OF dexamethasone
Merz Brand 1 of Dexamethasone
Merz brand 2 OF dexamethasone
Merz Brand 2 of Dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
MK 125
MLS001055412
MLS001332507
MLS001332508
MolMap_000018
MolPort-003-846-433
Mymethasone
Naquasone (veterinary)
NCGC00091019-01
NCGC00091019-02
NCGC00091019-03
NCGC00091019-04
NCGC00091019-05
nchembio809-comp2
NCI60_003067
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
NSC 34521
NSC34521
Ocu-trol
Ocu-Trol
Oradexon
OTO-104
Pet derm III
Pet Derm Iii
Pet Derm III
Pet-Derm Iii
PHL-Dexamethasone
PMS Dexamethasone elixir 0.5mg/5ML
PMS-Dexamethasone
Policort
Posurdex
Prednisolon F
Prednisolone F
Prodex
S1322_Selleck
SAM002548948
Sandoz dexamethasone
SGCUT00126
Sk-Dexamethasone
SK-Dexamethasone
SMP1_000092
SMR000857119
SMR001227192
Spectrum5_002019
Spoloven
ST50307091
Sunia sol D
Sunia Sol D
Superprednol
TL8003317
to_000038
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
UNII-7S5I7G3JQL
Visumetazone
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1
ZINC03875332
|
|
12 |
|
Dexamethasone acetate |
Approved, Investigational, Vet_approved |
Phase 4,Phase 1 |
|
1177-87-3 |
|
Synonyms:
16alpha-Methyl-9alpha-fluoroprednisolone 21-acetate
9alpha-Fluoro-16alpha-methylprednisolone acetate
Dexamethasone 21-acetate
|
Dexamethasone acetate anhydrous
Dexamethasone acetate, anhydrous
Dexamethasoni acetas
|
|
13 |
|
Methimazole |
Approved |
Phase 4,Phase 1,Phase 2,Not Applicable |
|
60-56-0 |
1349907
|
Synonyms:
1 Methyl 2 mercaptoimidazole
1,3-Dihydro-1-Methyl-2H-Imidazol-2-Thione
1,3-Dihydro-1-methyl-2H-imidazole-2-thione
1-METHYL-1,3-dihydro-2H-imidazole-2-thione
1-METHYL-1,3-DIHYDRO-2H-IMIDAZOLE-2-THIONE
1-Methyl-1,3-dihydroimidazole-2-thione
1-Methyl-1H-imidazole-2-thiol
1-Methyl-2-imidazolethiol
1-Methyl-2-Imidazolethione
1-Methyl-2-mercaptoimidazole
1-Methylimidazole-2(3H)-thione
1-Methylimidazole-2-thiol
1-Methyl-imidazole-2-thiol
1-Metylo 2 merkaptoimidazolem
1-Metylo 2 merkaptoimidazolem [Polish]
2-Mercapto-1-methylimidazole
2-Mercaptomethylimidazole
301507_ALDRICH
3-methyl-1H-imidazole-2-thione
46429_FLUKA
46429_RIEDEL
60-56-0
63760_FLUKA
85916-84-3
AC1LQFQZ
AC1Q3Z01
AC-785
AI3-60285
AKOS000119427
AKOS000269708
Basolan
BB_SC-1357
BIDD:GT0163
Bio-0823
BPBio1_000982
BSPBio_000892
BSPBio_001989
C4H6N2S
CAS-60-56-0
CHEBI:50673
CHEMBL1515
CID1349907
CPD000058376
CPD-11282
D00401
D008713
Danantizol
DB00763
DivK1c_000188
EINECS 200-482-4
Eli lilly brand OF methimazole
Eli Lilly Brand of Methimazole
Estedi brand OF methimazole
Estedi Brand of Methimazole
Favistan
Frentirox
Henning berlin brand OF methimazole
Henning Berlin Brand of Methimazole
Henning, thiamazol
Henning, Thiamazol
Hexal brand OF methimazole
Hexal Brand of Methimazole
Hexal, thiamazol
Hexal, Thiamazol
HMS1570M14
HMS1920L17
HMS2090B17
HMS2091D12
HMS2094C05
HMS500J10
HSDB 3361
I09-0350
IDI1_000188
Jones brand OF methimazole
Jones Brand of Methimazole
KBio1_000188
KBio2_001475
KBio2_004043
KBio2_006611
KBio3_001489
KBioGR_000515
KBioSS_001475
LS-7490
M0868
M8506_FLUKA
M8506_SIGMA
Mercaptazole
Mercasolyl
Mercazol
Mercazole
Mercazolyl
Mercazolylum
Merck brand OF methimazole
Merck Brand of Methimazole
|
Merkastan
Merkazolil
Mestinon, Regonol, Pyridostigmine Bromide
Metazolo
Methamazole
Methiamazole
Methimazol
methimazole
Methimazole
Methimazole (USP)
Methimazole [USAN:BAN]
Methimazolum
Methizol
Methylmercaptoimidazole
Methymazol
Metimazol
Metisol
Metizol
Metothyrin
Metothyrine
Metotirin
MLS000028413
MMZ
MolPort-000-563-838
MolPort-002-508-019
NCGC00016273-01
NCGC00016273-02
NCGC00094721-01
NCGC00094721-02
NCGC00178875-01
NINDS_000188
N-Methyl-2-mercaptoimidazole
Nourypharma brand OF methimazole
Nourypharma Brand of Methimazole
NSC 38608
NSC38608
Philopharm brand OF methimazole
Philopharm Brand of Methimazole
Prestwick_1010
Prestwick0_000786
Prestwick1_000786
Prestwick2_000786
Prestwick3_000786
S1609_Selleck
SAM002548951
Sanofi synthelabo brand OF methimazole
Sanofi Synthelabo Brand of Methimazole
SMR000058376
SPBio_001266
SPBio_002831
Spectrum_000995
SPECTRUM1500396
Spectrum2_001273
Spectrum3_000495
Spectrum4_000048
Spectrum5_000954
STK300018
STK802184
Strumazol
Strumazole
Tapazole
Tapazole (TN)
Tapuzole
Temmler brand OF methimazole
Temmler Brand of Methimazole
Thacapzol
Thiamazol
Thiamazol [INN-French]
Thiamazol henning
Thiamazol Henning
Thiamazol hexal
Thiamazol Hexal
thiamazole
Thiamazole
Thiamazole (JP15/INN)
Thiamazolum
Thiamazolum [INN-Latin]
Thimazol
Thimazole
Thycapsol
Thycapzol
Thymidazol
Thymidazole
Thyrozol
Tiamazol
Tiamazol [INN-Spanish]
Tiamazolo
Tiamazolo [DCIT]
Tirodril
UNII-554Z48XN5E
Usaf el-30
USAF el-30
WLN: T5N CNJ A BSH
ZINC01187543
|
|
14 |
|
Diclofenac |
Approved, Vet_approved |
Phase 4,Phase 3 |
|
15307-86-5 |
3033
|
Synonyms:
(2,6-Dichlorophenyl)amino]benzeneacetic acid
[2-(2,6-dichloroanilino)Phenyl]acetate
[2-(2,6-dichloroanilino)phenyl]acetic acid
[2-(2,6-dichloroanilino)Phenyl]acetic acid
[o-(2,6-Dichloroanilino)phenyl]acetic acid
{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid
15307-81-0 (mono-potassium salt)
15307-86-5
2-((2,6-Dichlorophenyl)amino)benzeneacetate
2-((2,6-dichlorophenyl)amino)benzeneacetic acid
2-((2,6-Dichlorophenyl)amino)benzeneacetic acid
2-(2,6-Dichloroanilino)phenylacetic Acid
2-(2,6-Dichlorophenylamino)phenylacetic acid
2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid
2-[2-(2,6-dichloroanilino)phenyl]acetic acid
2-[2-(2,6-Dichlorophenylamino)phenyl]acetic acid
2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
2b17
AC1L1F0T
Acetic acid, [o-(2,6-dichloroanilino)phenyl]- (8CI)
AKOS001579542
Allvoran
Apo-Diclo
Assaren
Benfofen
Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)- (9CI)
BIDD:GT0380
BPBio1_000516
BRD-K08252256-236-05-6
BRN 2146636
BSPBio_000468
BSPBio_002169
C01690
Cataflam
CHEBI:47381
CHEMBL139
CID3033
cMAP_000014
D07816
D30801
D3748
DB00586
Delphimix
dichlofenac
Dichlofenac
Dichlofenal
Dichronic
Diclac
Diclobenin
diclofenac
Diclofenac (INN)
Diclofenac [INN:BAN]
Diclofenac acid
Diclofenac Acid
Diclofenac potassium
Diclofenac Potassium
Diclofenac sodium
Diclofenac Sodium
Diclofenac, sodium
Diclofenaco
Diclofenaco [INN-Spanish]
Diclofenacum
Diclofenacum [INN-Latin]
Diclofenamic acid
Diclomelan
Diclonate P
Diclophenac
Diclo-Phlogont
Diclo-Puren
Diclord
Dicloreum
Dicloreuma
Dicrofenac
DIF
DivK1c_000272
DivK1c_000402
Dolobasan
Duravolten
Dyloject
Ecofenac
Effekton
EINECS 239-348-5
|
Feloran
GP-45,840
henyl)-o-aminophenylacetic acid
HMS2090C10
HMS501E04
HSDB 7234
I14-7739
IDI1_000272
IDI1_000402
ISV-205
KBio1_000272
KBio1_000402
KBio2_001410
KBio2_002306
KBio2_003978
KBio2_004874
KBio2_006546
KBio2_007442
KBio3_001389
KBio3_002786
KBioGR_001051
KBioGR_002306
KBioSS_001410
KBioSS_002308
Kriplex
Lopac0_000441
LS-11575
MolPort-000-003-072
N-(2,6-Dichlorop
NCGC00021125-01
Neriodin
NINDS_000272
NINDS_000402
Novapirina
Novo-Difenac
Novo-Difenac SR
Nu-Diclo
Oprea1_011155
Orthofen
Orthophen
Ortofen
Pennsaid
Prestwick0_000594
Prestwick1_000594
Prestwick2_000594
Prestwick3_000594
Primofenac
Prophenatin
ProSorb-D
Rhumalgan
SBB068617
Sodium diclofenac
Solaraze
Solaraze (TN)
Solaraze T
SPBio_001081
SPBio_002687
Spectrum_000930
Spectrum2_000991
Spectrum3_000385
Spectrum4_000506
Spectrum5_000867
SR 38
SR-38
STK984493
Transfenac
Tsudohmin
UNII-144O8QL0L1
UNM000001216103
Valetan
Voldal
Voltaflan
Voltaren
Voltaren Ophtha
Voltaren ophthalmic
Voltaren Ophthalmic
Voltaren Rapide
Voltaren SR
Voltaren-XR
Voltarol
Xenid
|
|
15 |
|
Metoprolol |
Approved, Investigational |
Phase 4 |
|
37350-58-6, 51384-51-1 |
4171
|
Synonyms:
(+/-)-metoprolol
(RS)-Metoprolol
1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol
1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol
1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
1-(isopropylamino)-3-[4-(2-Methoxyethyl)phenoxy]propan-2-ol
1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol
3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol
37350-58-6
51384-51-1
54163-88-1
AB00053499
AC-19022
AC1L1HKM
AstraZeneca Brand of Metaoprolol Tartrate
AstraZeneca Brand of Seloken
Beatrolol
Beloc
Beloc duriles
Beloc Duriles
Beloc-duriles
BelocDuriles
Beloc-Duriles
Betaloc
Betaloc astra
Betaloc Astra
Betaloc-astra
BetalocAstra
Betaloc-Astra
Betalok
BRD-A03623303-045-02-0
C07202
CCRIS 4198
CGP 2175
CGP2175
CGP-2175
CHEBI:6904
CHEMBL13
CID4171
CR-XL, Metoprolol
D008790
D02358
DB00264
dl-Metoprolol
DL-metoprolol
DL-Metoprolol
Dutoprol
EINECS 253-483-7
EINECS 257-166-4
H 93 26
|
H 9326
H 93-26
HMS2090B15
HSDB 6531
I01-7125
I06-0125
Jsp006606
L000669
Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate
Lopresor
Lopresoretic
LOPRESSIDONE
Lopressor
Lopressor HCT
LS-122450
Meijoprolol
Metohexal
metoprolol
Metoprolol (USAN/INN)
Metoprolol [USAN:INN:BAN]
Metoprolol CR XL
Metoprolol CR-XL
Metoprolol succinate
Metoprolol tartrate
Metoprolol Tartrate
Metoprololum
Metoprololum [INN-Latin]
Metroprolol
MolPort-005-938-039
NCGC00021148-02
NCGC00021148-03
NCGC00021148-04
Novartis Brand of Metprolol Tartrate
Preblok
Prelis
Presolol
Seloken
Seloken AstraZeneca Brand
Selopral
Selo-Zok
Seroken
Spesicor
Spesikor
Succinate, metoprolol
Tartrate, metoprolol
Tartrate, Metoprolol
Toprol
Toprol XL
ToprolXL
Toprol-XL
TOPROL-XL
UNII-GEB06NHM23
|
|
16 |
|
Propranolol |
Approved, Investigational |
Phase 4,Phase 3,Not Applicable |
|
525-66-6 |
4946
|
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(isopropylamino)-3-(1-Naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
13013-17-7
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
AY 64043
AY-20694
Bedranol
Beprane
Berkolol
Beta Neg
Betachron
Betadren
Betalong
Beta-Neg
beta-Propranolol
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
BPBio1_001040
b-Propranolol
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
C07407
C16H21NO2
Cardinol
Caridolol
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
cMAP_000071
Corpendol
D,L-Propranolol
D08443
DB00571
Deralin
Dexpropranolol
DivK1c_000023
Dl-Propranolol Hydrochloride
DL-Propranolol hydrochloride
Dociton
Duranol
Efektolol
EINECS 208-378-0
EINECS 235-867-6
Elbrol
etalong
Etalong
Euprovasin
Frekven
Herzbase
HMS2090L21
Hydrochloride, propranolol
ICI 45520
IDI1_000023
Ikopal
Inderal
Inderal hydrochloride
Inderal La
Inderalici
Inderex
Inderide
INDERIDE-40/25
INDERIDE-80/25
|
Inderol
Indobloc
Innopran XL
InnoPranXL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
Lopac0_000896
LS-122410
LS-184129
Migrastat
MolPort-001-794-623
Naprilin
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Pranolol
Prano-Puren
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
propranolol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol [INN:BAN]
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol hydrochloride
Propranolol Hydrochloride
propranololo
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor line
Reducor Line
Rexigen
Sagittol
Sawatal
Servanolol
Sloprolol
SPBio_001361
SPBio_001658
SPBio_003093
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
STK735510
Sumial
Tesnol
UNII-9Y8NXQ24VQ
β-propranolol
β-Propranolol
|
|
17 |
|
Dinoprost Tromethamine |
Approved, Vet_approved |
Phase 4 |
|
38562-01-5 |
5282415
|
Synonyms:
(5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoic acid tris salt
(E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid
1,3-Propanediol, 2-amino-2-(hydroxymethyl)-, (5Z,9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oate (salt)
2-amino-2-(hydroxymethyl)propane-1,3-diol
36300-07-9
38473-38-0
38562-01-5
51553-13-0
5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, tham
7-(3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-5-heptenoic acid, tromethamine salt
AC1NR011
C20H34O5.C4H11NO3
CHEMBL1200896
CID5282415
D01352
DB01160
Dinolytic
Dinoprost trometamol
dinoprost tromethamine
Dinoprost tromethamine (JAN/USP)
Dinoprost tromethamine [USAN:JAN]
Dinoprost, trometamol salt
EINECS 254-002-3
Ensaprost
Enzaprost F compd. with trisamine
LS-125841
Lutalyse
Lutalyse (Veterinary)
MLS000028821
MolPort-003-939-186
NSC 196515
P0424_SIGMA
P5069_SIGMA
Panacelan F tromethamine salt
|
PGF2-alpha tham
PGF2alpha THAM
PGF2-alpha THAM
PGF2-alpha tris salt
PGF2alpha tromethamine
PGF2-alpha tromethamine
PGF2-alpha tromethamine salt
PGF2alpha-Tris
Pronalgon F
Prosta-5,13-dien-1-oic acid, (5Z,9-alpha,11-alpha,13E,15S)-9,11,15-trihydroxy-, compd. with trimethylolaminomethane
Prosta-5,13-dien-1-oic acid, (5Z,9-alpha,11-alpha,13E,15S)-9,11,15-trihydroxy-,compd. with trimethylolaminomethane
Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,11alpha,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
Prostaglandin F(sub 2a) tromethamine
Prostaglandin F2a tromethamine
Prostaglandin F2alpha tham
Prostaglandin F2-alpha THAM
Prostaglandin F2-alpha THAM salt
PROSTAGLANDIN F2ALPHA TRIS SALT
prostaglandin F2alpha tromethamine
Prostaglandin F2-alpha tromethamine
Prostaglandin F-2alpha tromethamine salt
Prostalmon F
Prostamate
Prostin F2 alpha
Prostin F2 Alpha
Prostin F2 alpha (TN)
Protaglandin F2-alpha-tham salt
SMR000058792
THAM PGF2-alpha
Tromethamine prostaglandin F2-alpha
U 14585
U-14,583E
U-14583E
UNII-CT6BBQ5A68
Zinoprost
|
|
18 |
|
Bimatoprost |
Approved, Investigational |
Phase 4,Phase 3,Early Phase 1 |
|
155206-00-1 |
5311027
|
Synonyms:
(5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide
(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide
(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
155206-00-1
15M
267244-98-4
5-Heptenamide,7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ehtyl-,(5Z)
AC1NSJUW
AGN 192024
AGN-192024
Bimataprost [USAN:INN:BAN]
bimatoprost
Bimatoprost
Bimatoprost (JAN/USAN/INN)
Bimatoprost [USAN:INN:BAN]
bimatoprostum
|
Bimatoprostum
CHEBI:39562
CHEBI:51230
CHEMBL1200963
CID5311027
D02724
DB00905
DB06863
I06-1275
I06-1277
Latisse
LS-181817
Lumigan
Lumigan (TN)
NCGC00181745-01
UNII-QXS94885MZ
ZINC04474405
|
|
19 |
|
Dinoprost |
Approved, Investigational |
Phase 4 |
|
551-11-1 |
5283078
|
Synonyms:
(+)-Prostaglandin F2a
(5Z,13E)-(15S)-9-alpha,11-alpha,15-Trihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-9-alpha,11-alpha,15-Trihydroxyprosta-5,13-dienoic acid
(5Z,13E,15S)-9a,11a,15-Trihydroxyprosta-5,13-dien-1-Oate
(5Z,13E,15S)-9a,11a,15-Trihydroxyprosta-5,13-dien-1-Oic acid
(5Z,9a,11a,13E,15S)-9,11,15-Trihydroxy-prosta-5,13-dien-1-Oate
(5Z,9a,11a,13E,15S)-9,11,15-Trihydroxy-prosta-5,13-dien-1-Oic acid
(9alpha,11alpha,15)-Trihydroxyprosta-(5Z,13E)-dien-1-Oate
(9alpha,11alpha,15)-Trihydroxyprosta-(5Z,13E)-dien-1-Oic acid
7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoate
7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid
9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-Oate
9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-Oic acid
9,11,15-Trihydroxyprosta-5Z,13E-dien-1-Oate
9,11,15-Trihydroxyprosta-5Z,13E-dien-1-Oic acid
9a,11a,15(S)-Trihydroxy-5-cis-13-trans-prostadienoate
9a,11a,15(S)-Trihydroxy-5-cis-13-trans-prostadienoic acid
9a,11a-PGF2
9a,11a-PGF2a
9alpha,11beta PGF2
9alpha,11beta-PGF2
alpha, PGF2
Amoglandin
Cyclosin
|
Dinifertin
Dinoprost
dinoprosta
Enzaprost
Enzaprost F
Estrofan
F2 alpha, Prostaglandin
F2a Isoprostane
F2alpha, Prostaglandin
Glandin N
L-PGF2-alpha
L-Prostaglandin F2-alpha
Panacelan
PGF2
PGF2 alpha
PGF2a
PGF2alpha
Prostaglandin F2
Prostaglandin F2 alpha
Prostaglandin F2alpha
Prostamate
Prostarmon F
Prostin F 2 alpha
Protamodin
|
|
20 |
|
leucovorin |
Approved |
Phase 4,Not Applicable |
|
58-05-9 |
6006
143
|
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-formyltetrahydrofolic acid
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
Acid, folinic
Acide folinique
Calcium citrovorum factor
Calcium folinate
Calcium leucovorin
Citrovorum factor
Factor, citrovorum
folinate
Folinate
Folinate, calcium
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid SF
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolate
|
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucovorin
Leucovorin calcium
Leucovorin folinic acid
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monosodium salt
Leucovorinum
Leukovorin
Leukovorum
Levoleucovorin
L-leucovorin
L-Leucovorin
L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Rescuvolin
Welcovorin
Wellcovorin
|
|
21 |
|
rituximab |
Approved |
Phase 4,Phase 2,Phase 3,Phase 1 |
|
174722-31-7 |
10201696
|
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
Ig gamma-1 chain C region
|
Mabthera
MabThera
Rituxan
rituximab
|
|
22 |
|
Methotrexate |
Approved |
Phase 4,Not Applicable |
|
59-05-2, 1959-05-2 |
126941
|
Synonyms:
4-amino-10-Methylfolate
4-amino-10-methylfolic acid
4-amino-10-Methylfolic acid
4-amino-N(10)-Methylpteroylglutamate
4-amino-N(10)-methylpteroylglutamic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Dicesium salt methotrexate
Emtexate
Emtexic acid
Folex
HDMTX
Hydrate, methotrexate
L-Amethopterin
Ledertrexate
Ledertrexic acid
Metatrexan
Methopterin
Methotextrate
Methotrate
Methotrexat
|
Méthotrexate
Methotrexate hydrate
Methotrexate sodium
Methotrexate Sodium
Methotrexate, (D)-isomer
Methotrexate, (DL)-isomer
Methotrexate, dicesium salt
Methotrexate, disodium salt
Methotrexate, sodium salt
Methotrexatum
Methotrexic acid
Methylaminopterin
Methylaminopterinum
Metotrexato
Mexate
MTX
N-[4-[[(2,4-diamino-6-Pteridinyl)methyl]methylamino]benzoyl]-L-glutamate
N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
N-[4-[[(2,4-diamino-6-Pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
N-Bismethylpteroylglutamic acid
N-Bismethylpteroylglutamic Acid
Rheumatrex
Sodium, methotrexate
Trexall
|
|
23 |
|
Folic Acid |
Approved, Nutraceutical, Vet_approved |
Phase 4,Not Applicable |
|
59-30-3 |
6037
|
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
AI3-26387
AKOS000503224
Antianemia factor
Apo-Folic
ARONIS014410
b9, Vitamin
BIDD:ER0563
BIDD:GT0641
BIF0608
bmse000299
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat b activ
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
Facid
Factor U
FOL
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
|
Folsaeure
Folsan
Folsaure
Folsäure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
Incafolic
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
Liver lactobacillus casei factor
Liver Lactobacillus casei factor
LS-2157
Millafol
Mission prenatal
Mittafol
MLS001304016
MLS001335861
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-Pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
nchembio.108-comp10
Nifolin
Nifolin [Denmark]
NINDS_000494
Novofolacid
Novofolacid [Canada]
N-Pteroyl-L-glutamate
N-pteroyl-L-glutamic acid
N-Pteroyl-L-glutamic acid
NSC 3073
PGA
PGA (VAN)
Prestwick_230
Prestwick3_000627
PteGlu
Pteroylglutamate
Pteroylglutamic acid
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
Serum Folate Level
SMP2_000137
SMR000471860
SPBio_001357
Spectrum_001381
SPECTRUM1502020
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin b9
Vitamin B9
Vitamin Bc
Vitamin BC
Vitamin be
Vitamin Be
Vitamin m
Vitamin M
|
|
24 |
|
Prednisolone hemisuccinate |
Experimental |
Phase 4,Phase 2,Phase 3,Not Applicable |
|
2920-86-7 |
|
Synonyms:
(+)-prednisolone hemisuccinate
Prednisolonbisuccinat
Prednisolone 21-hemisuccinate
Prednisolone 21-succinate
|
Prednisolone bisuccinate
Prednisolone hydrogen succinate
Prednisolone succinate
|
|
25 |
|
Hormones |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
26 |
|
Antithyroid Agents |
|
Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable |
|
|
|
27 |
|
Hormones, Hormone Substitutes, and Hormone Antagonists |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
28 |
|
Antimetabolites |
|
Phase 4,Phase 3,Phase 2,Not Applicable |
|
|
|
29 |
|
Hormone Antagonists |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
30 |
|
glucocorticoids |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
31 |
|
Neuroprotective Agents |
|
Phase 4,Phase 2,Phase 3,Not Applicable |
|
|
|
32 |
|
Autonomic Agents |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
33 |
|
Antineoplastic Agents, Hormonal |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
34 |
|
Antiemetics |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
35 |
|
Prednisolone acetate |
|
Phase 4,Phase 2,Phase 3,Not Applicable |
|
|
|
36 |
|
Anti-Inflammatory Agents |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
37 |
|
Protective Agents |
|
Phase 4,Phase 2,Phase 3,Not Applicable |
|
|
|
38 |
|
Gastrointestinal Agents |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
39 |
|
Peripheral Nervous System Agents |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
40 |
|
Methylprednisolone acetate |
|
Phase 4,Phase 2,Phase 3,Not Applicable |
|
|
|
41 |
|
Ophthalmic Solutions |
|
Phase 4,Phase 2 |
|
|
|
42 |
|
Viscosupplements |
|
Phase 4,Not Applicable |
|
|
|
43 |
|
Adjuvants, Immunologic |
|
Phase 4,Not Applicable |
|
|
|
44 |
|
Central Nervous System Depressants |
|
Phase 4,Phase 2,Phase 3,Not Applicable |
|
|
|
45 |
|
Anesthetics |
|
Phase 4,Phase 2,Phase 3,Not Applicable |
|
|
|
46 |
|
Anesthetics, Local |
|
Phase 4,Phase 2,Phase 3,Not Applicable |
|
|
|
47 |
|
Pharmaceutical Solutions |
|
Phase 4,Phase 3,Phase 2 |
|
|
|
48 |
|
Proxymetacaine |
|
Phase 4 |
|
|
|
49 |
|
Immunologic Factors |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
50 |
|
Micronutrients |
|
Phase 4,Phase 2,Phase 3,Not Applicable |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 130)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy |
Unknown status |
NCT01056419
|
Phase 4 |
Propylthiouracil |
2 |
A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy |
Unknown status |
NCT01969019
|
Phase 4 |
methylprednisolone, prednisone |
3 |
Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease |
Unknown status |
NCT01738243
|
Phase 4 |
Hyaluronic Acid Gel injection;Saline injection |
4 |
Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease |
Completed |
NCT00946296
|
Phase 4 |
Potassium Iodide |
5 |
Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone |
Completed |
NCT00917241
|
Phase 4 |
MMI combined with IID;MMI |
6 |
Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study) |
Completed |
NCT01458600
|
Phase 4 |
Diclofenac;Methimazole;L-thyroxin;Propranolol;Metoprolol |
7 |
Antithyroid Drugs During Radioiodine Therapy |
Completed |
NCT00150137
|
Phase 4 |
Methimazole |
8 |
Block-replacement Therapy During Radioiodine Therapy |
Completed |
NCT00150124
|
Phase 4 |
MTZ+LT4;Methimazole |
9 |
Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) |
Completed |
NCT02059655
|
Phase 4 |
Bimatoprost;Eye drop solution |
10 |
Liver Function After Intravenous Methylprednisolone Administration |
Completed |
NCT03667157
|
Phase 4 |
every week IVMP therapy;very high doses IVMP therapy |
11 |
Is the Routine Pressure Dressing After Thyroidectomy Necessary? |
Completed |
NCT00400465
|
Phase 4 |
|
12 |
Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix TM) Administered in Healthy Adolescents |
Completed |
NCT00534638
|
Phase 4 |
|
13 |
Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections |
Completed |
NCT01599273
|
Phase 4 |
subconjunctival triamcinolone injection |
14 |
Rituximab (RTX) Therapy in Patients With Active TAO |
Recruiting |
NCT02378298
|
Phase 4 |
Rituximab;Iv Methylprednisolone;peroral methylprednisolone and Methotrexate |
15 |
Using A Novel Classification System in Intravenous GCs Therapy of TAO: A Multi-central, Randomized, Open, Superior Trial |
Recruiting |
NCT03107078
|
Phase 4 |
Glucocorticoids |
16 |
A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' Orbitopathy |
Not yet recruiting |
NCT03098225
|
Phase 4 |
Methylprednisolone |
17 |
Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease |
Not yet recruiting |
NCT02339142
|
Phase 4 |
intravenous corticosteroids (methylprednisolone) |
18 |
The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients. |
Withdrawn |
NCT01927406
|
Phase 4 |
Prostaglandin Analog;Timolol |
19 |
Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction |
Withdrawn |
NCT01272414
|
Phase 4 |
Botulinum Toxin Type A;Saline injection |
20 |
Early Levothyroxine Post Radioactive Iodine |
Unknown status |
NCT01950260
|
Phase 2, Phase 3 |
Levothyroxine |
21 |
The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions |
Unknown status |
NCT01204359
|
Phase 3 |
|
22 |
Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy |
Unknown status |
NCT01809444
|
Phase 2, Phase 3 |
Prednisone+placebo of Doxycycline;Doxycycline+placebo of Prednisone |
23 |
Effect of Percutaneous Botulinum Toxin A Injection on Natural Course of Upper Lid Retraction in Thyroid Eye Disease |
Unknown status |
NCT00370734
|
Phase 2, Phase 3 |
Botulinum toxin A injection |
24 |
Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism |
Completed |
NCT01039818
|
Phase 3 |
|
25 |
Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance |
Completed |
NCT01295333
|
Phase 3 |
the early prophylactic introduction of low dose of LT4 (50 µg/d) at 15 days post-ablation;The initiation of LT4 as soon as the first biological signs of hypothyroidism. |
26 |
Trial of Rituximab for Graves' Ophthalmopathy |
Completed |
NCT00595335
|
Phase 2, Phase 3 |
Rituximab;Saline;Methylprednisolone |
27 |
Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues |
Completed |
NCT02155049
|
Phase 3 |
bimatoprost 0.03% |
28 |
Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease) |
Completed |
NCT01297699
|
Phase 3 |
Tocilizumab (RoActemra®);Sterile 0.9% Sodium Chloride |
29 |
Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism |
Recruiting |
NCT03303053
|
Phase 3 |
Cholestyramine Powder 4g;Prednisolone;Standard treatment |
30 |
Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy |
Recruiting |
NCT03066076
|
Phase 3 |
Antithyroid Drug |
31 |
Bupivacaine Injection of Eye Muscles to Treat Strabismus |
Recruiting |
NCT01616108
|
Phase 2, Phase 3 |
Bupivacaine |
32 |
Treatment of Graves´Ophthalmopathy With Diclofenac or Simvastatin (GO-DS) |
Recruiting |
NCT03131726
|
Phase 3 |
Simvastatin 40mg;Diclofenac Potassium 50 MG |
33 |
The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy |
Recruiting |
NCT01579539
|
Phase 3 |
Methylprednisolone;Esomeprazole |
34 |
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study |
Active, not recruiting |
NCT03298867
|
Phase 3 |
|
35 |
Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study |
Enrolling by invitation |
NCT03461211
|
Phase 3 |
|
36 |
The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease |
Not yet recruiting |
NCT02422368
|
Phase 2, Phase 3 |
Methylprednisolone + ASTED;Methylprednisolone +Placebo |
37 |
The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED) |
Not yet recruiting |
NCT02393183
|
Phase 2, Phase 3 |
ASTED |
38 |
Role of the Microbiome in Graves' Orbitopathy |
Unknown status |
NCT02373995
|
Phase 1, Phase 2 |
|
39 |
Doxycycline Treatment in Mild Graves' Orbitopathy |
Unknown status |
NCT02203682
|
Phase 2 |
Doxycycline;placebo |
40 |
Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients |
Completed |
NCT02993302
|
Phase 2 |
1α-D3;Placebos |
41 |
A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease |
Completed |
NCT02713256
|
Phase 2 |
CFZ533 |
42 |
Radioactive Iodide Therapy for Pediatric Graves' Disease |
Completed |
NCT01269749
|
Phase 2 |
ATD Group |
43 |
Rituximab in the Treatment of Graves' Disease |
Completed |
NCT00150111
|
Phase 1, Phase 2 |
Methimazole;Rituximab |
44 |
rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter |
Completed |
NCT00145366
|
Phase 2 |
Recombinant human thyrotropin (Thyrogen) |
45 |
Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy |
Completed |
NCT00424151
|
Phase 1, Phase 2 |
Rituximab |
46 |
Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy |
Completed |
NCT01727973
|
Phase 1, Phase 2 |
Doxycycline |
47 |
Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease |
Completed |
NCT01868997
|
Phase 2 |
teprotumumab;normal saline |
48 |
Celecoxib for Thyroid Eye Disease |
Recruiting |
NCT02845336
|
Phase 2 |
Celecoxib;artificial tears |
49 |
Effects of Atorvastatin in Graves' Orbitopathy (GO) |
Not yet recruiting |
NCT03110848
|
Phase 2 |
Atorvastatin;Methylprednisolone |
50 |
A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease |
Terminated |
NCT01114503
|
Phase 2 |
Otelixizumab - low dose;Otelixizumab - medium low dose;Otelixizumab - medium high dose;Otelixizumab - high dose;Otelixizumab;Methylprednisolone |
Cochrane evidence based reviews: graves disease
|